DV
Dividend Vision

PBYI — Puma Biotechnology Inc

Puma Biotechnology Inc (PBYI)

Total return is -34.6% over the past 14.3 years, 655.8 points behind SPY at 621.2%. Its deepest 1-year drawdown was 25.8%.

PBYI is an equity fund that holds Puma Biotechnology Inc stock, providing direct exposure to a single biotechnology company. The fund does not currently pay distributions and has no reported yield profile. This fund appeals primarily to investors seeking concentrated exposure to a specific biotech company rather than those pursuing dividend income.

PBYI key facts

Asset type
Stock
Asset class
Equity
Inception date
04/20/2012
Last close
$8.83
Market cap
$422,465,504
Average volume
232900.0
Beta
1.188
Payout ratio
0.0
P/E ratio
17.2917
Forward P/E
3.459
EPS
$0.48